“FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025057. doi:10.4084/MJHID.2025.057.